Loading...
Park Ha Biological Technology Co., Ltd.
PHH•NASDAQ
Consumer Defensive
Household & Personal Products
$1.10
$-1.89(-63.21%)
Park Ha Biological Technology Co., Ltd. (PHH) Financial Performance & Statements
Review Park Ha Biological Technology Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-3.14%
↓ 3.14%
Operating Income Growth
-32.77%
↓ 32.77%
Net Income Growth
-43.83%
↓ 43.83%
Operating Cash Flow Growth
659.04%
↑ 659.04%
Operating Margin
33.32%
↑ 33.32%
Gross Margin
91.80%
↑ 91.80%
Net Profit Margin
20.09%
↑ 20.09%
ROE
38.003%
↑ 38.003%
ROIC
50.92%
↑ 50.92%
Park Ha Biological Technology Co., Ltd. (PHH) Financial Statements
Explore quarterly and annual reports for Park Ha Biological Technology Co., Ltd. stock.
| Metric | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $35.00M | $50.00M | $109.00M | $121.00M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $35.00M | $50.00M | $109.00M | $121.00M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $28.00M | $32.00M | $50.00M | $84.00M |
| Operating Expenses | -$69.00M | -$80.00M | -$134.00M | -$212.00M |
| Total Costs & Expenses | -$69.00M | -$80.00M | -$134.00M | -$212.00M |
| Interest Income | $4.00M | $3.00M | -$13.00M | $10.00M |
| Interest Expense | $15.00M | $17.00M | $20.00M | $20.00M |
| Depreciation & Amortization | $2.00M | $3.00M | $3.00M | $4.00M |
| EBITDA | -$32.00M | -$27.00M | -$22.00M | -$87.00M |
| EBITDA Ratio | -$0.91 | -$0.54 | -$0.20 | -$0.72 |
| Operating Income | -$34.00M | -$30.00M | -$25.00M | -$91.00M |
| Operating Income Ratio | -$0.97 | -$0.60 | -$0.23 | -$0.75 |
| Other Income/Expenses (Net) | $8.00M | -$156.00M | -$250.00M | $13.00M |
| Income Before Tax | -$36.00M | -$26.00M | -$7.00M | -$78.00M |
| Income Before Tax Ratio | -$1.03 | -$0.52 | -$0.06 | -$0.64 |
| Income Tax Expense | $1.00M | $4.00M | $24.00M | -$36.00M |
| Net Income | -$37.00M | -$30.00M | -$31.00M | -$42.00M |
| Net Income Ratio | -$1.06 | -$0.60 | -$0.28 | -$0.35 |
| EPS | -$1.13 | -$0.92 | -$0.95 | -$0.87 |
| Diluted EPS | -$1.13 | -$0.92 | -$0.95 | -$0.87 |
| Weighted Avg Shares Outstanding | $32.67M | $32.65M | $32.63M | $48.21M |
| Weighted Avg Shares Outstanding (Diluted) | $32.67M | $32.65M | $32.63M | $48.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan